A Prescription for Change: The Looming Crisis in Drug Development (The Luther H. Hodges Jr. and Luther H. Hodges Sr. Series on Business, Entrepreneurship, and Public Policy)
| Author | : | |
| Rating | : | 4.41 (837 Votes) |
| Asin | : | 1469630621 |
| Format Type | : | paperback |
| Number of Pages | : | 352 Pages |
| Publish Date | : | 2017-05-09 |
| Language | : | English |
DESCRIPTION:
. Louis. Michael Kinch is Associate Vice Chancellor and Director of the Center for Research Innovation in Biotechnology at Washington University in St
Well explained and illustrated with useful anecdotes.--Science MagazineA cogent and comprehensive view of where the drug industry is today and how it got there.--Health Affairs. Packs in detail, but keeps it readable.--CompressionAn informative and fascinating read for anyone with an interest in the drug discovery process, scientists, healthcare professionals, investors, regulators, or those who just want to see our economy flourish and public health to be improved for the global benefit to society or just to protect an individual 401K plan. Highly recommend this well-written book as a
"Gain an understanding on the pharmaceutical industry" according to David R.. by studying its history. Michael Kinch shares his insider perspective, providing his readers with a thorough understanding of the current state of drug development. It is the author's hope that by understanding how we got here, we will figure out ways to improve going forward.
Kinch relates stories of the individuals and organizations that built the modern infrastructure that supports the development of innovative new medicines. In spite of these past successes--and indeed because of them--our ability to deliver new medicines may be quickly coming to an end. Moving from the beginning of the twentieth century to the present, A Prescription for Change reveals how changing business strategies combined with scientific hubris have altered the way new medicines are discovered, with dire implications for both health and the economy.To explain how we have arrived at this pivotal moment, Michael Kinch recounts the history of pharmaceutical and biotechnological advances in the twentieth century. He shows that an accelerating cycle of acquisition and downsizing is cannibalizing that infrastructure Kinch demonstrates the dismantling of the pharmaceutical and biotechnological research and development enterprises could also provide opportunities to innovate new models that sustain and expand the introduction of newer and better breakthrough medicines in the years to come.. The introduction of new medicines has dramatically improved the quantity and quality of individual and public heal